Treatment of Hyperprolactinemia in a Symptomatic Patient with Suspected Medication-Induced Prolactin Elevation

This protocol addresses a symptomatic patient with suspected medication-induced hyperprolactinemia — specifically, a patient currently using a drug known to cause prolactin elevation. The clinical picture points to that medication as the most likely cause of elevated prolactin.

The initial management strategy centres on the offending medication itself. Whether discontinuation of that drug is clinically feasible is the pivotal first question — the answer determines the path forward. The full structured protocol specifies what follows from there.

Complete clinical criteria, sequencing, and decision points are available in the full protocol below.

The primary target is normalisation of serum prolactin. With drug-induced hyperprolactinemia, prolactin levels typically return to normal within a matter of days once the causative medication is appropriately managed.